Skip to main content
Log in

Anticancer and radiosensitizing evaluation of novel sulfonamides with quinoline and pyrimidoquinoline groups

  • Published:
Research on Chemical Intermediates Aims and scope Submit manuscript

Abstract

Because of the reported anticancer activity of quinolines and pyrimidoquinolines containing the biologically active sulfonamide moiety, a new series of quinoline and pyrimidoquinoline derivatives were synthesized and tested for in-vitro anticancer activity against liver-cancer cells. Reaction of 5,5-dimethylcyclohexane-1,3-dione 1 with sulfanilamide 2 in ethanol yielded the corresponding enaminone 3. Treatment of enaminone 3 with 2-(4-methylbenzylidene)malononitrile 4 gave the corresponding strategic starting material quinoline 6. The quinoline-o-aminocarbonitrile 6 was used to synthesize new series of quinolines 8, 11, 1520 and pyrimidoquinolines 7, 10, 1214. The structures of the synthesized compounds were confirmed by microanalysis, IR, 1H NMR, and 13C NMR spectroscopy, and use of mass spectral data. Almost all the compounds had significant activity against human cancer cell line HEPG2 compared with doxorubicin as a positive control. The most potent compounds, 7, 10, and 20, were also evaluated for their ability to enhance the killing effect of γ-radiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Scheme 2
Scheme 3
Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. P. Nasveld, S. Kitchener, Trans. R. Soc. Trop. Med. Hyg. 99, 2–5 (2005)

    Article  Google Scholar 

  2. A. Mahamoud, A. Chevalier, A. Davin-Regli, J. Barbe, J.M. Pages, Curr. Drug Targ. 7, 843–847 (2006)

    Article  CAS  Google Scholar 

  3. N. Muruganantham, R. Sivakumar, N. Anbalagan, V. Gunasekaran, J.T. Leonard, Biol. Pharm. Bull. 27, 1683–1687 (2004)

    Article  CAS  Google Scholar 

  4. L. Strekowski, J.L. Mokrosz, V.A. Honkan, A. Czarny, M.T. Cegla, S.E. Patterson, R.L. Wydra, R.F. Schinazi, J. Med. Chem. 34, 1739–1746 (1991)

    Article  CAS  Google Scholar 

  5. M.M. Ghorab, F.A. Ragab, H.I. Heiba, Y.M. Nissan, W.M. Ghorab, Arch. Pharm. Res. 35, 1335–1346 (2012)

    Article  CAS  Google Scholar 

  6. Y.H. Kim, K.J. Shin, T.G. Lee, E. Kim, M.S. Lee, S.H. Ryu, P.G. Suh, Biochem. Pharmacol. 69, 1333–1341 (2005)

    Article  CAS  Google Scholar 

  7. Y.L. Zhao, Y.L. Chen, F.S. Chang, C.C. Tzeng, Eur. J. Med. Chem. 40, 792–797 (2005)

    Article  CAS  Google Scholar 

  8. J. Drews, Science 287, 1960–1964 (2000)

    Article  CAS  Google Scholar 

  9. E. Selvaag, H. Anholt, J. Moan, P.J. Thune, Photochem. Photobiol. B Biol. 38, 88–93 (1997)

    Article  CAS  Google Scholar 

  10. C.T. Supuran, A. Scozzafava, Exp. Opin. Ther Patents 10, 75–600 (2000)

    Article  Google Scholar 

  11. C.T. Supuran, A. Scozzafava, Curr. Med. Chem. Immunol. Endocr. Metab. Agents 1, 61–97 (2001)

    Article  CAS  Google Scholar 

  12. C.W. Thornber, Chem. Soc. Rev. 8, 563–580 (1979)

    Article  CAS  Google Scholar 

  13. F. Abbate, A. Casini, T. Owa, A. Scozzafava, C.T. Supuran, Bioorg. Med. Chem. Lett. 14, 217–223 (2004)

    Article  CAS  Google Scholar 

  14. M.M. Ghorab, F.A. Ragab, M.M. Hamed, Eur. J. Med. Chem. 44, 4211–4217 (2009)

    Article  CAS  Google Scholar 

  15. S. Eswaran, A.V. Adhikari, N.S. Shetty, Eur. J. Med. Chem. 44, 4637–4647 (2009)

    Article  CAS  Google Scholar 

  16. M.M. Ghorab, F.A. Ragab, S.I. Alqasoumi, A.M. Alafeefy, S.A. Aboulmagd, Eur. J. Med. Chem. 45, 171–178 (2010)

    Article  CAS  Google Scholar 

  17. M.S. Al-said, M.M. Ghorab, S.I. Alqasoumi, E.M. El-Hossary, E. Noaman, Eur. J. Med. Chem. 45, 3011–3018 (2010)

    Article  CAS  Google Scholar 

  18. M.M. Ghorab, F.A. Ragab, E. Noaman, H.I. Heiba, E.M. El-Hossary, Arzneimittelforschung 57, 795–803 (2007)

    CAS  Google Scholar 

  19. M.S. Al-Said, M.M. Ghorab, M.S. Al-Dosari, M.M. Hamid, Eur. J. Med. Chem. 46, 201–207 (2011)

    Article  CAS  Google Scholar 

  20. S.I. Alqasoumi, A.M. Al-Taweel, A.M. Alafeefy, M.M. Ghorab, E. Naoman, Eur. J. Med. Chem. 45, 1849–1853 (2010)

    Article  CAS  Google Scholar 

  21. M.M. Ghorab, F.A. Ragab, H.I. Heiba, M.G. El-Gazzar, M.G. El-Gazzar, Acta Pharm. 61, 415–425 (2011)

    Article  CAS  Google Scholar 

  22. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, M.R. Boyd, INCI. J. Natl Cancer Inst. 82, 1107–1112 (1990)

    Article  CAS  Google Scholar 

  23. Y. Nishimura, Int. J. Clin. Oncol. 9, 414–420 (2004)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mostafa M. Ghorab.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghorab, M.M., Shaaban, M.A., Heiba, H.I. et al. Anticancer and radiosensitizing evaluation of novel sulfonamides with quinoline and pyrimidoquinoline groups. Res Chem Intermed 41, 647–661 (2015). https://doi.org/10.1007/s11164-013-1218-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11164-013-1218-9

Keywords

Navigation